| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1437 | 1050 | 13 |
| Full Text Views | 20 | 2 | 1 |
| PDF Downloads | 17 | 0 | 0 |
Liposomes, Muramyl Dipeptide Derivatives, and Nontoxic Lipid a Derivatives as Adjuvants for Human Malaria Vaccines
George S. N. Hui
George S. N. Hui
Department of Tropical Medicine, University of Hawaii, Honolulu, Hawaii
Search for other papers by George S. N. Hui in
Current site
Google Scholar
PubMed
Search for other papers by George S. N. Hui in
Current site
Google Scholar
PubMed
Studies indicate that adjuvant formulations based on liposomes, nontoxic lipid A, and muramyl peptide derivatives are safe and effective for vaccine use. Future research on the immunobiology of these adjuvants as well as the mechanisms by which adjuvants can alter the quality of immune responses may play an important role in determining their efficacy in malaria vaccines.
Author Notes
| Past two years | Past Year | Past 30 Days | |
|---|---|---|---|
| Abstract Views | 1437 | 1050 | 13 |
| Full Text Views | 20 | 2 | 1 |
| PDF Downloads | 17 | 0 | 0 |